Pentasa Prolonged Release tab. 500 mg

Land: Jordanië

Taal: Engels

Bron: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Werkstoffen:

Mesalazine 500 mg

Beschikbaar vanaf:

مستودع البتراء للمواد الطبية - Petra Drug Store

ATC-code:

A07EC02

INN (Algemene Internationale Benaming):

Mesalazine 500 mg

Dosering:

500 mg

Eenheden in pakket:

100

Geproduceerd door:

FERRING INTERNATIONAL CENTER S.A(FICSA)/SWI (سويسرا)

Product samenvatting:

37.85 :سعر الجمهور + الضريبة

Bijsluiter

XXXXXXXXXX
PENTASA
®
1g Prolonged Release Tablet
PENTASA
®
500 mg Prolonged Release Tablets
For use in adults and children from the age of 6 years.
Active ingredient: Mesalazine.
Read all of this leaflet carefully before you start taking this
medicine
because it contains important information for you.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you. Do not pass it on to
others. It
may harm them, even if their symptoms are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes
any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1.
What PENTASA
®
are and what they are used for
2.
What you need to know before you take PENTASA
®
3.
How to take PENTASA
®
4.
Possible side effects
5.
How to store PENTASA
®
6.
Contents of the pack and other information
1.
What PENTASA
®
prolonged release tablets are and what they are used for
PENTASA
®
prolonged release tablets are an intestinal therapeutic agent.
PENTASA
®
prolonged release tablets are used in:
-
Acute treatment of ulcerative colitis (inflammation of the large
intestine with
ulceration) and prophylaxis for relapse.
-
Treatment for symptomatic improvement in cases of active Crohn’s
disease.
2.
What you need to know before you take PENTASA
®
prolonged release
tablets
Do not take PENTASA
®
prolonged release tablets
-
If you are allergic to Mesalazine, salicylic acid or its derivatives
(e.g.
acetylsalicylic acid) or to any of the other ingredients of this
medicine (listed
in section 6).
-
If you have severe liver and renal function impairment.
Warnings and precautions
Talk to your doctor or pharmacist before taking PENTASA
®
prolonged release
tablets.
Tell your doctor before using PENTASA
®
prolonged release tablets
-
If you have ever developed a severe skin rash or skin peeling,
blistering and/
or mouth sores after using mesalazine.
Take special care wi